by Nikos Koukidis | Mar 13, 2020 | Ad-hoc, Finance, News, Press
Sales pass 300-million mark for the first time at 313.7 million CHF EBIT margin rises to 19.9%, EBITDA margin to 27.8% Net income up sharply to 54.2 million CHF Initial successes in oligonucleotide market Growth targets raised thanks to rising demand Proposed dividend...
